SGK494 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the protein SGK494, which is part of the SGK (serum- and glucocorticoid-induced kinase) family of proteins. These kinases are serine/threonine-specific and play a pivotal role in a variety of cellular processes by modulating the phosphorylation of target proteins. SGK494, like other members of its family, is involved in regulating key intracellular signaling pathways, particularly those related to cell growth, survival, and migration. The inhibition of SGK494 can lead to the disruption of its normal kinase activity, thus affecting downstream signaling cascades involved in maintaining the balance of cellular processes. The molecular structure of SGK494 inhibitors typically allows them to interact with the ATP-binding site of the kinase, preventing its activation or blocking its enzymatic function.
Structurally, SGK494 inhibitors are designed to exhibit high specificity to SGK494, minimizing the likelihood of cross-reactivity with other kinases in the SGK family or unrelated kinases. This specificity is often achieved through modifications to the core chemical scaffold, which enhances the binding affinity to SGK494's active site while maintaining selectivity. The development and optimization of these inhibitors involve thorough understanding of the protein's structure, including key regions like the catalytic domain, where most inhibitors interact. By modulating SGK494 activity, these compounds serve as valuable tools in studying the protein's role in cell signaling and understanding its broader implications in various physiological processes. The design and synthesis of SGK494 inhibitors contribute significantly to the broader field of kinase research, enabling deeper exploration of kinase regulation and the molecular mechanisms driving cellular dynamics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, a kinase upstream of many SGKs, reducing the phosphorylation and activation of SGKs. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Acts similarly to LY294002 by inhibiting PI3K, leading to decreased SGK activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which can be involved in the regulation of SGKs, thus altering SGK activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, which is upstream of ERK, another kinase that can regulate SGK function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to mTOR and inhibits its activity, which can affect SGKs through mTOR's role in cell signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may interact with SGKs in some signaling pathways, modulating SGK activity. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
Inhibits mTOR kinase activity, similar to Rapamycin, affecting downstream SGK activity. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $179.00 $700.00 | 9 | |
Selective inhibitor of p70 S6 kinase, which is downstream of PI3K/Akt/mTOR pathway and can affect SGKs. | ||||||
GSK 2334470 | 1227911-45-6 | sc-364501 sc-364501A | 10 mg 50 mg | $199.00 $1165.00 | 1 | |
Inhibits PDK1, which is involved in the activation of SGKs through phosphorylation. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Inhibits Akt, which is upstream of several SGKs, thus reducing the phosphorylation and activation of SGKs. | ||||||